{"name":"Neurotec Pharma","slug":"neurotec-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPRGhlYThxbmlPYjEweDRZbVp6UXJZS20zZVZiYS1kdXFkOTBCdGxtcVJVNHNydkxQM2oweW5EXzRQWlItRy1DSFVHX0dQZTVPbzBBRXdXbWh5WTN2MkI0SnN0OWVzM21lWDE3TFJrSDQxNXRuSDRJNkZxWDdTWWhqNUlnSGhydm5sRUtsVW5jY21mblNkSllFSjVqZGh3TklyZkhFT1c2SWE0OTRNUnE2Z0x3?oc=5","date":"2026-02-19","type":"pipeline","source":"Science|Business","summary":"Viewpoint: neurotechnology deserves an EU research moonshot - Science|Business","headline":"Viewpoint: neurotechnology deserves an EU research moonshot - Science|Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNemNNZlJrUXN0NnRlSGhJd0tMZldDbWEwWHlxbWE2U1oyZnF0ekplQjFlSE5mWFkwVDJxR044cGZIMnd1RDEwSWw5d25sWVk1NDFTWXJDTk8xUHkzQmUzSGJVcnpoZzBZQzNqVXR1ZEhFNXFGdUpWMkV2S1pVb3Jxay1R?oc=5","date":"2026-01-22","type":"pipeline","source":"BioSpace","summary":"The New Gold Rush in Brain Science - BioSpace","headline":"The New Gold Rush in Brain Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFA2emFqcWllSnhvVjl0YXdBLWFIbW1zOGZPRkFGZlRZS3RTMlBRU005ekd4RnVQRXhDdlcyeHNlcFN1Vnh4U1pTdUlraHhGV3pIYkJ3bkVLcnVNMHd3SGJsdVBzNGxNekNzSlhkeA?oc=5","date":"2026-01-15","type":"pipeline","source":"Karolinska Institutet","summary":"Winter School of Clinical Neurotechnology - Karolinska Institutet","headline":"Winter School of Clinical Neurotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOV3NKX19DdDZteTZ2djUtUTRmVUR4bjBuQ0ltTDZ5U1RUQmVKUGZrMVcxdGJvUm5pYV9uT0VCbk9DcFFnbG1VdTdmalBsUTNmZ2xqRlgzVjQ4NVhNLUdCTEp1anEtZ015MU9DNmQ3OFRUQmRaZDBFenkyY2tGS1l1V1lWbTlteXRmUEl6Y3B0aGZWaEtJMHJadnhWTVlNRFk1UjBDT1Ric3I?oc=5","date":"2025-08-27","type":"patent","source":"pharmaphorum","summary":"Neurotech patents in Europe: Methods, medical devices, and the EPC exclusion - pharmaphorum","headline":"Neurotech patents in Europe: Methods, medical devices, and the EPC exclusion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQb2c1N25DdE5Od2pDTC1MYUtmNFVwdFVnQ3FLZWVlZkdXbEJ2dGNQUUxNNTlLZWtjeEUxNzBMOE5lNFJqY3NqOF9qc3dfNE1zallENmtIZk5UamdOX3ZOdzhRRXpfR2JkOC1DNlBUR2k4Z1pCY0lCdmNOSkswLTBESkNhTFVCOVQ2VEFWUjg5LXF1V0xxbFViRmpKSDUwZw?oc=5","date":"2025-04-25","type":"pipeline","source":"Fierce Biotech","summary":"Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders - Fierce Biotech","headline":"Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOUzJidXBjMnRlejFrWERJeE0tQTlBbmh0TW9zLVR0NjQxaXFzWlhid2xnTnpCeHZQU1lqeDctMnJDUWlMcFRCZXp2QjI1Tm1pa1RqaHh1b3IxRmZGNmlUa2pHZlVNT21VV0M0RWtLUktteThfVXFEQlJoZEJEdlBXeWI3OHMyZV80TzdGeDFlVEs1V0sxTU1YcWFYaUU0VHdWRnlNZHU2WXNvZFhtckZrakdfS0h4Vnc?oc=5","date":"2025-03-10","type":"regulatory","source":"Fierce Pharma","summary":"Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto - Fierce Pharma","headline":"Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNOGhQd1l4R1VmMGpfdmdnRHJ4ZFVCUW44SlRDaHl2RTJfa1poWG1PS2xseXZYTERiM2lsM1owQ0VMZ3Mxb29LSFh2Nmx2R2VoektXNXpxZ2RDZVNvUy02bFFfVHcyNnppTERoSVlBVGZjWHhsQzNUV3ZVR29GaUhzRmMzNmR6T3htN0ViN2Y4bl9mUnNhcnJNLTEwREtfemtuQ1d0cThCMFJuMHFxMy0wYnd1TzVkUQ?oc=5","date":"2025-03-06","type":"regulatory","source":"CGTLive®","summary":"Neurotech’s Encapsulated Cell Therapy Encelto Approved by FDA for Macular Telangiectasia Type 2 - CGTLive®","headline":"Neurotech’s Encapsulated Cell Therapy Encelto Approved by FDA for Macular Telangiectasia Type 2 - CGTLive®","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdEgyM3hGUGp1NnR2bkczbmUya1FxVlBwajhoQVNDUWVickF1bkNJWFh3SmtyT2t3a05XNzAyeWhIYXFRTU9MT21VYS0tVkQ4dUw5eHVMTmxuN2hTUUhpSlh2Tl8tREF1cnBiN3BweWQ1ZFBncHBXMmVfcXNMSm9Zd3RUMU9LOGxUUURZY3d4S09yX1hCOGo4SGt1R29GWEh4bktHaVpJSEE?oc=5","date":"2024-11-22","type":"pipeline","source":"Healthcare Brew","summary":"Are we entering a neurotechnology renaissance in healthcare? - Healthcare Brew","headline":"Are we entering a neurotechnology renaissance in healthcare?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOelRkR08wUnJNRjhNakVBTnpYeEVGTzZpQktIV1RxUTVtMFlWbm9vWEJxVFozbkpZZmpUeTRmT01mMzBuV3FFUmVfWWdkOGQxbGhZMk9IWkpQanNTdXdRbE5ENXJNaGs4VmR5Z29fVkYtRXl2UEZXV3dWUGNRWDA5QjlpQnF3ZlJnSWRqZUQ1Z3h6czloY0xqS19vdmE5RVZpRm5XNTVEbHlwV1VSdDJxWDNwVXZUOHlvS0hr?oc=5","date":"2024-06-24","type":"pipeline","source":"Eyes On Eyecare","summary":"Neurotech Pharma earns BLA priority review for MacTel cell therapy - Eyes On Eyecare","headline":"Neurotech Pharma earns BLA priority review for MacTel cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPaFVNMFhqUkZXeGtMNm1IV0ZhaVdwa2lyc1BsUWg4NUIyaEVjOG1JRjZiS3ctSW5pVlFFbkNZOFM1YjdzN0NoTTM4Y2s3cXgtM0dvZlhrVGx5cW5aeXdINW1TelBjcm1PanBrZWdwNmYyS2lRd2tkRzJQYU9kRGpDWkNvZTRmYTgyZXQzdnpLV1hMRU1JUnhDZHAzLTU2X2NiMlpqazN5TFotb1FHcldjb3hNeHE3bWc?oc=5","date":"2024-04-05","type":"trial","source":"Ophthalmology Times Europe","summary":"ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501 - Ophthalmology Times Europe","headline":"ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZWZ4S2d6cUQ4ZFdTUWx1Q3pOMm5nRTdIbGc2UkdQaUluaW5aZ2J4WFlnNFduVzlmWTIwcC1zZlhOb3FiUFpNTS05Mk5MLS1RTzlXOWlmdnNvbkpKTFFXQzZZd2JDaFBOdWtkR1Zxd2gwcGgzVmdLWGNoWTVndlk5eEpRZWZWdVRWWTNxMXZESWhEZGk4MmdVZ3J0TjhqdzdSZWdFVXNZOF9pT2FG?oc=5","date":"2023-09-13","type":"pipeline","source":"businesswire.com","summary":"Alex Gorsky Joins Neurotech’s Board as Lead Director - businesswire.com","headline":"Alex Gorsky Joins Neurotech’s Board as Lead Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxQQ29uTnh0dnBIOTBBQzFtb1JHVENqRk5fVXhEbTBqY0hDemVRUXBpX0RhSjNoMzF3MFJueUJOTnZ6SE1nMmpxdXRZU0d3NWZhcTF2SzhBT3JoVFRSWXE4RlVRdm92SnBWQWtSQy1DWGZqbXJEbl9CWTNLZG51elZsb3B0T0htMzk5VlVfQXdTLUhOS0VzVVRiV3NqMHAweUw1Y1BGbUs2blZ5MlZTMi1PblFxR2VSVG5zM0MxMmduWW56Z2dzbFdCc0E4Q0VYWnZZb2NMYlktUGZtR0prb3VUQnQ2dlpMTzlxeXRXenFSWmx3SjAzTjFFM1FDNXJnd1ZocERqV1MwcVRCOGpJazNOaA?oc=5","date":"2019-02-12","type":"regulatory","source":"prnewswire.com","summary":"Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2 - prnewswire.com","headline":"Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiect","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}